Abstract
Pregnancy in patients with pulmonary arterial hypertension (PAH) is associated with a maternal mortality of 30–50% despite modern treatment modalities. The majority of maternal deaths in PAH patients occur either during labor and delivery or within 1 month postpartum. Cardiovascular collapse is attributed to a mismatch between the physiologic limitations of PAH and the changes that occur with pregnancy and delivery. In the Unites States, there is no consensus on the management of PAH in pregnancy. Several case reports have been published describing improved maternal–fetal outcomes, likely due to new advanced PH therapies, earlier diagnosis of PAH, and an adoption of a multidisciplinary treatment approach. We present five cases of gravid PAH patients successfully managed at our institution with a description of our standardized multidisciplinary treatment approach.
Similar content being viewed by others
References
Badesch DB et al (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):S55–S66
McGoon MD, Kane GC (2009) Pulmonary hypertension: diagnosis and management. Mayo Clin Proc 84(2):191–207
Weiss BM et al (1996) Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 31(7):1650–1657
McCaffrey RM, Dunn LJ (1964) Primary pulmonary hypertension in pregnancy. Obstet Gynecol Surv 19:567–591
Curry R, Swan L, Steer PJ (2009) Cardiac disease in pregnancy. Curr Opin Obstet Gynecol 21(6):508–513
Geva T et al (1997) Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133(1):53–59
Bonnin M et al (2005) Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 102(6):1133–1137 (discussion 5A–6A)
Smedstad KG, Cramb R, Morison DH (1994) Pulmonary hypertension and pregnancy: a series of eight cases. Can J Anaesth 41(6):502–512
Higton AM et al (2009) Pulmonary hypertension in pregnancy: two cases and review of the literature. Intern Med J 39(11):766–770
Stewart R et al (2001) Pregnancy and primary pulmonary hypertension: successful outcome with epoprostenol therapy. Chest 119(3):973–975
Weiss BM, Hess OM (2000) Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 21(2):104–115
Madden BP (2009) Pulmonary hypertension and pregnancy. Int J Obstet Anesth 18(2):156–164
Pitkin RM et al (1990) Pregnancy and congenital heart disease. Ann Intern Med 112(6):445–454
Pritchard JA (1965) Changes in the blood volume during pregnancy and delivery. Anesthesiology 26:393–399
Katz R, Karliner JS, Resnik R (1978) Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 58(3 Pt 1):434–441
Monnery L, Nanson J, Charlton G (2001) Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 87(2):295–298
Church AC et al (2009) Epoprostenol use in a national pulmonary hypertension centre from 1997 to 2007. Thorax 64(7):642
Bates SM et al (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American college of chest physicians evidence-based clinical practice guidelines, 8th edn. Chest 133(6):844S–886S
Barst RJ et al (2009) Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 54(1):S78–S84
Garabedian MJ et al (2010) Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy. J Perinatol 30(9):628–631
The Wellcome Foundation (2000) Flolan package insert. The Wellcome Foundation Ltd, London
United Therapeutics Corporation (2010) Remodulin (treprostinil) injection package insert. United Therapeutics Corporation, Research Triangle Park
Spence S et al (1999) Teratogenic effects of the endothelin receptor antagonist L-753, 037 in the rat. Reprod Toxicol 13(1):15–29
Gilman DH (1991) Caesarean section in undiagnosed Eisenmenger’s syndrome. Report of a patient with a fatal outcome. Anaesthesia 46(5):371–373
Barash PG et al (1981) Catheter-induced pulmonary artery perforation. Mechanisms, management, and modifications. J Thorac Cardiovasc Surg 82(1):5–12
Conflict of interest
C. J. Daniels has performed clinical trials with Actelion, Pfizer, Gilead, United Therapeutics. J. S. Smith and J. Mueller have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smith, J.S., Mueller, J. & Daniels, C.J. Pulmonary Arterial Hypertension in the Setting of Pregnancy: A Case Series and Standard Treatment Approach. Lung 190, 155–160 (2012). https://doi.org/10.1007/s00408-011-9345-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-011-9345-9